{"id":"https://openalex.org/W2391597003","doi":null,"title":"In vivo study on pharmacokinetics and pharmacodynamics of P167 modified liposomal doxorubicin in rats","display_name":"In vivo study on pharmacokinetics and pharmacodynamics of P167 modified liposomal doxorubicin in rats","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2391597003","mag":"2391597003"},"language":"en","primary_location":{"id":"mag:2391597003","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-LCZZ201401002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764559294","display_name":"Chinese Journal of Clinical Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Clinical Pharmacy","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065031667","display_name":"TU Yingfen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"TU Yingfen","raw_affiliation_strings":["Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Healthy Science Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Healthy Science Center","institution_ids":["https://openalex.org/I20231570"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5065031667"],"corresponding_institution_ids":["https://openalex.org/I20231570"],"apc_list":null,"apc_paid":null,"fwci":0.2245,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.42762343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7459999918937683},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.7049999833106995},{"id":"https://openalex.org/keywords/peptide-modification","display_name":"peptide modification","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9480000138282776},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8510000109672546},{"id":"https://openalex.org/keywords/c6-glioma","display_name":"C6 glioma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/long-circulation","display_name":"long circulation","score":0.5220000147819519},{"id":"https://openalex.org/keywords/tumor-penetration","display_name":"tumor penetration","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8381789922714233},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8178044557571411},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7894628047943115},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.718044638633728},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.6563601493835449},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6431752443313599},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5402763485908508},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5191073417663574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3829282820224762},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18544432520866394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1377527415752411},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11613589525222778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09053832292556763},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08217224478721619},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2391597003","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-LCZZ201401002.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764559294","display_name":"Chinese Journal of Clinical Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Clinical Pharmacy","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2165824272","https://openalex.org/W2334372776","https://openalex.org/W2766213446","https://openalex.org/W1570509890","https://openalex.org/W2128090828","https://openalex.org/W4399049773","https://openalex.org/W2370985058","https://openalex.org/W2051787604","https://openalex.org/W2392318412","https://openalex.org/W2754152900"],"abstract_inverted_index":{"AIM":[0],"To":[1],"study":[2],"the":[3,10,73,95,104,152,241],"effect":[4],"of":[5,14,56,75,106,125,154,162,176,190,219,229,240,243],"P167":[6,21,220,244],"peptide":[7,22,221],"modification":[8,218],"on":[9],"pharmacokinetics":[11],"and":[12,20,46,94,117,184,198],"pharmacodynamics":[13],"doxorubicin-loaded":[15,24],"liposomes(":[16,25],"DOX-SSL).":[17],"METHODS":[18],"DOX-SSL":[19],"modified":[23],"DOX-P167-SSL)":[26],"were":[27,36,92,97,112,178],"prepared":[28],"using":[29],"pH":[30],"gradient":[31],"method.":[32],"Sprague":[33],"dawley":[34],"rats":[35,43,96],"randomly":[37],"divided":[38,98],"into":[39,99,166],"2":[40],"groups(":[41],"six":[42],"per":[44,140],"group)":[45],"treated":[47,206],"with":[48,114,136],"DOX-SSL,DOX-P167-SSL":[49],"via":[50,119],"tail":[51,120,158],"vein":[52,121,159],"at":[53,122],"a":[54,123,224,238],"dose":[55,124],"2.":[57,126],"5":[58,127,138],"mg\u00b7kg-1respectively.":[59],"HPLC":[60],"internal":[61,66],"standard":[62,67],"method(":[63],"daunomycin":[64],"as":[65],"substance)":[68],"was":[69,82,130,148,209],"used":[70,83],"to":[71,84,103,150,223],"determine":[72],"concentration":[74],"doxorubicin":[76],"in":[77,226,234],"blood":[78],"serum.":[79],"WinNonlin":[80],"software":[81],"calculate":[85],"pharmacokinetic":[86],"parameters.":[87],"Tumor-bearing":[88],"rats(":[89],"C6":[90],"glioma)":[91],"established":[93],"3":[100,134],"groups":[101],"according":[102],"results":[105],"magnetic":[107],"resonance":[108],"imaging(":[109],"MRI).":[110],"Rats":[111],"administered":[113],"physiological":[115],"saline,DOX-SSL":[116],"DOX-P167-SSL":[118,177,208],"mg\u00b7kg-1,respectively.":[128],"Administration":[129],"made":[131],"once":[132],"every":[133],"days":[135],"total":[137],"doses":[139],"rat.":[141],"Relative":[142],"tumor":[143],"growth":[144],"ratio(":[145],"T":[146,204],"/C%)":[147],"calculated":[149],"evaluate":[151],"efficacy":[153],"drug.":[155],"RESULTS":[156],"After":[157],"administration,the":[160],"biodistribution":[161],"two":[163],"formulations":[164],"fitted":[165],"two-compartment":[167],"model.":[168],"The":[169,203,217],"t1":[170],"/2(":[171,173],"\u03b1),t1":[172],"\u03b2)and":[174],"AUC":[175],"4.":[179],"89":[180],"min,837.":[181],"57":[182],"min":[183,197],"610.":[185],"35":[186],"min\u00b7mg\u00b7L-1respectively,lower":[187],"than":[188],"that":[189],"DOX-SSL(":[191],"16.":[192],"23":[193],"min,2":[194],"940.":[195],"48":[196],"1":[199],"301.":[200],"16":[201],"min\u00b7mg\u00b7L-1).":[202],"/C%":[205],"by":[207],"7.":[210],"32%,while":[211],"37.":[212],"07%":[213],"for":[214],"DOX-SSL.":[215],"CONCLUSION":[216],"leads":[222],"decline":[225],"long":[227],"circulation":[228],"DOX-SSL,but":[230],"an":[231],"obvious":[232],"increase":[233],"efficacy,it":[235],"may":[236],"be":[237],"result":[239],"penetration":[242],"peptide.":[245]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}